Axogen, Inc. Announces Full Launch of Avive+ Soft Tissue Matrix™

UF startup Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced the launch of its newest product, Avive+ Soft Tissue Matrix™.

Avive+™ is intended for use as a soft tissue barrier and is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing.

“Product innovation is integral to our mission at Axogen,” stated Karen Zaderej, Chairman, CEO, and President of Axogen, which incubated at UF Innovate | Accelerate @ Sid Martin Biotech in Alachua. “With the introduction of Avive+ Soft Tissue Matrix, we are excited to enhance our comprehensive solutions for nerve protection and address a significant need for patients with compression or non-transected nerve injuries.”

Read more about Axogen, Inc. Announces Full Launch of Avive+ Soft Tissue Matrix™.